Asia Pacific Dengue Treatment Market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 OBJECTIVES OF THE STUDY
• 1.2 MARKET DEFINITION
• 1.3 OVERVIEW OF THE ASIA-PACIFIC DENGUE TREATMENT MARKET
• 1.4 CURRENCY AND PRICING
• 1.5 LIMITATIONS
• 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

• 2.1 MARKETS COVERED
• 2.2 GEOGRAPHICAL SCOPE
• 2.3 YEARS CONSIDERED FOR THE STUDY
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
• 2.6 MULTIVARIATE MODELLING
• 2.7 MARKET APPLICATION COVERAGE GRID
• 2.8 PRODUCT LIFELINE CURVE
• 2.9 DBMR MARKET POSITION GRID
• 2.10 VENDOR SHARE ANALYSIS
• 2.11 SECONDARY SOURCES
• 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PESTEL ANALYSIS
• 4.2 PORTER'S FIVE FORCES

5 ASIA-PACIFIC DENGUE TREATMENT MARKET: REGULATIONS

• 5.1 U.S. REGULATORY SCENARIO FOR DENGUE TREATMENT
• 5.2 EUROPE REGULATORY SCENARIO FOR DENGUE TREATMENT
• 5.3 DEVELOPING COUNTRIES REGULATORY FRAMEWORK
• 5.4 LEGISLATION FOR CONTROL OF DENGUE IN SINGAPORE
• 5.5 DVCRN DEVELOPING VACCINE REGULATORS NETWORK

6 MARKET OVERVIEW

• 6.1 DRIVERS
  • 6.1.1 RISING DENGUE INCIDENCE RATE RESULT IN THE DEMAND FOR EFFECTIVE TREATMENT
  • 6.1.2 RISING WAVE OF DENGUE VACCINE LAUNCHES
  • 6.1.3 GOVERNMENT INITIATIVES AND VACCINATION PROGRAMS
  • 6.1.4 GROWTH OF MEDICAL INSURANCE IN EMERGING COUNTRIES
• 6.2 RESTRAINTS
  • 6.2.1 DELAY IN THE APPROVAL PROCESS OF VACCINES
  • 6.2.2 LACK OF AWARENESS AND HEALTHCARE INFRASTRUCTURE FOR TREATMENT OF DENGUE
  • 6.2.3 DIFFICULTY IN THE DETECTION ASSAY FOR DENGUE
• 6.3 OPPORTUNITIES
  • 6.3.1 STRATEGIC COLLABORATION WITHIN THE PHARMACEUTICAL INDUSTRY FUELS THE MARKET
  • 6.3.2 GROWING NUMBER OF PIPELINE VACCINES FOR DENGUE TREATMENT
  • 6.3.3 RISING R&D INVESTMENT AND ACTIVITIES
• 6.4 CHALLENGES
  • 6.4.1 HEALTHCARE SERVICES ARE LIMITEDLY ACCESSIBLE IN RURAL AREAS
  • 6.4.2 HIGH COSTS OF TREATMENT RESTRICT THE FEASIBILITY OF COST-EFFECTIVE SOLUTIONS

7 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY STRAINS

• 7.1 OVERVIEW
• 7.2 DENV-2
• 7.3 DENV-3
• 7.4 DENV-1
• 7.5 DENV-4
• 7.6 OTHERS

8 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY TYPE

• 8.1 OVERVIEW
• 8.2 VACCINES
  • 8.2.1 DENGVAXIA (CYD-TDV)
  • 8.2.2 QDENGA
• 8.3 ACETAMINOPHEN
  • 8.3.1 PARENTERAL
  • 8.3.2 ORAL
  • 8.3.3 OTHER

9 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY SEVERITY

• 9.1 OVERVIEW
• 9.2 MILD TO MODERATE DENGUE
• 9.3 SEVERE DENGUE

10 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

• 10.1 OVERVIEW
• 10.2 PARENTERAL
  • 10.2.1 SUB-CUTANEOUS
  • 10.2.2 INTRAVENOUS
• 10.3 ORAL
  • 10.3.1 TABLET
  • 10.3.2 CAPSULES
  • 10.3.3 OTHERS

11 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY MODE OF PURCHASE

• 11.1 OVERVIEW
• 11.2 PRESCRIPTION
• 11.3 OVER-THE-COUNTER (OTC)

12 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY GENDER

• 12.1 OVERVIEW
• 12.2 MALE
• 12.3 FEMALE

13 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY AGE

• 13.1 OVERVIEW
• 13.2 ADULT
• 13.3 PEDIATRIC
• 13.4 GERIATRIC

14 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY END USER

• 14.1 OVERVIEW
• 14.2 HOSPITAL
• 14.3 SPECIALTY CLINICS
• 14.4 HOME HEALTHCARE
• 14.5 OTHERS

15 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

• 15.1 OVERVIEW
• 15.2 RETAIL PHARMACIES
• 15.3 HOSPITAL PHARMACIES
• 15.4 ONLINE PHARMACIES

16 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY REGION

• 16.1 ASIA-PACIFIC
  • 16.1.1 INDIA
  • 16.1.2 CHINA
  • 16.1.3 JAPAN
  • 16.1.4 INDONESIA
  • 16.1.5 MALAYSIA
  • 16.1.6 THAILAND
  • 16.1.7 AUSTRALIA
  • 16.1.8 SOUTH KOREA
  • 16.1.9 SINGAPORE
  • 16.1.10 PHILIPPINES
  • 16.1.11 REST OF ASIA-PACIFIC

17 ASIA-PACIFIC DENGUE TREATMENT MARKET: COMPANY LANDSCAPE

• 17.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

18 SWOT ANALYSIS

19 COMPANY PROFILE

• 19.1 SANOFI
  • 19.1.1 COMPANY SNAPSHOT
  • 19.1.2 REVENUE ANALYSIS
  • 19.1.3 COMPANY SHARE ANALYSIS
  • 19.1.4 PRODUCT PORTFOLIO
  • 19.1.5 RECENT DEVELOPMENTS
• 19.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • 19.2.1 COMPANY SNAPSHOT
  • 19.2.2 REVENUE ANALYSIS
  • 19.2.3 COMPANY SHARE ANALYSIS
  • 19.2.4 PRODUCT PORTFOLIO
  • 19.2.5 RECENT DEVELOPMENTS
• 19.3 VIATRIS INC.
  • 19.3.1 COMPANY SNAPSHOT
  • 19.3.2 REVENUE ANALYSIS
  • 19.3.3 COMPANY SHARE ANALYSIS
  • 19.3.4 PRODUCT PORTFOLIO
  • 19.3.5 RECENT DEVELOPMENTS
• 19.4 JOHNSON & JOHNSON SERVICES, INC.
  • 19.4.1 COMPANY SNAPSHOT
  • 19.4.2 REVENUE ANALYSIS
  • 19.4.3 COMPANY SHARE ANALYSIS
  • 19.4.4 PRODUCT PORTFOLIO
  • 19.4.5 RECENT DEVELOPMENT
• 19.5 GSK PLC.
  • 19.5.1 COMPANY SNAPSHOT
  • 19.5.2 REVENUE ANALYSIS
  • 19.5.3 COMPANY SHARE ANALYSIS
  • 19.5.4 PRODUCT PORTFOLIO
  • 19.5.5 RECENT DEVELOPMENTS
• 19.6 AUROBINDO PHARMA
  • 19.6.1 COMPANY SNAPSHOT
  • 19.6.2 REVENUE ANALYSIS
  • 19.6.3 PRODUCT PORTFOLIO
• 19.7 BAXTER
  • 19.7.1 COMPANY SNAPSHOT
  • 19.7.2 REVENUE ANALYSIS
  • 19.7.3 PRODUCT PORTFOLIO
• 19.8 FRESENIUS KABI USA
  • 19.8.1 COMPANY SNAPSHOT
  • 19.8.2 PRODUCT PORTFOLIO
  • 19.8.3 RECENT DEVELOPMENTS
• 19.9 HIKMA PHARMACEUTICALS
  • 19.9.1 COMPANY SNAPSHOT
  • 19.9.2 REVENUE ANALYSIS
  • 19.9.3 PRODUCT PORTFOLIO
  • 19.9.4 RECENT DEVELOPMENT
• 19.10 PERRIGO COMPANY PLC
  • 19.10.1 COMPANY SNAPSHOT
  • 19.10.2 REVENUE ANALYSIS
  • 19.10.3 PRODUCT PORTFOLIO
  • 19.10.4 RECENT DEVELOPMENT
• 19.11 PFIZER INC.
  • 19.11.1 COMPANY SNAPSHOT
  • 19.11.2 REVENUE ANALYSIS
  • 19.11.3 PRODUCT PORTFOLIO
  • 19.11.4 RECENT DEVELOPMENTS
• 19.12 SUN PHARMACEUTICAL INDUSTRIES LTD
  • 19.12.1 COMPANY SNAPSHOT
  • 19.12.2 REVENUE ANALYSIS
  • 19.12.3 PRODUCT PORTFOLIO
  • 19.12.4 RECENT DEVELOPMENT
• 19.13 TEVA PHARMACEUTICALS USA, INC.
  • 19.13.1 COMPANY SNAPSHOT
  • 19.13.2 REVENUE ANALYSIS
  • 19.13.3 PRODUCT PORTFOLIO
  • 19.13.4 RECENT DEVELOPMENT

20 QUESTIONNAIRE

21 RELATED REPORTS

LIST OF TABLES

• TABLE 1 THREE PHASES FOR HEALTH PROTECTION OUTLINED BY THE EUROPEAN WORLD HEALTH ORGANIZATION
• TABLE 2 IMPACT OF DELAY IN APPROVAL PROCESS
• TABLE 3 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 4 ASIA-PACIFIC DENV-2 IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 5 ASIA-PACIFIC DENV-3 IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 6 ASIA-PACIFIC DENV-1 IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 7 ASIA-PACIFIC DENV-4 IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 8 ASIA-PACIFIC OTHERS IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 9 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 10 ASIA-PACIFIC VACCINES IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 11 ASIA-PACIFIC VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 12 ASIA-PACIFIC VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 13 ASIA-PACIFIC VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 14 ASIA-PACIFIC ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 15 ASIA-PACIFIC ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 16 ASIA-PACIFIC ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 17 ASIA-PACIFIC ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 18 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 19 ASIA-PACIFIC MILD TO MODERATE DENGUE IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 20 ASIA-PACIFIC SEVERE DENGUE IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 21 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 22 ASIA-PACIFIC PARENTERAL IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 23 ASIA-PACIFIC PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 24 ASIA-PACIFIC ORAL IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 25 ASIA-PACIFIC ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 26 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 27 ASIA-PACIFIC PRESCRIPTION IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 28 ASIA-PACIFIC OVER-THE-COUNTER (OTC) IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 29 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 30 ASIA-PACIFIC MALE IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 31 ASIA-PACIFIC FEMALE IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 32 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 33 ASIA-PACIFIC ADULT IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 34 ASIA-PACIFIC PEDIATRIC IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 35 ASIA-PACIFIC GERIATRIC IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 36 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 37 ASIA-PACIFIC HOSPITAL IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 38 ASIA-PACIFIC SPECIALITY CLINICS IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 39 ASIA-PACIFIC HOME HEALTHCARE IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 40 ASIA-PACIFIC OTHERS IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 41 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 42 ASIA-PACIFIC RETAIL PHARMACIES IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 43 ASIA-PACIFIC HOSPITAL PHARMACIES IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 44 ASIA-PACIFIC ONLINE PHARMACIES IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 45 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 46 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
• TABLE 47 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 48 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 49 ASIA-PACIFIC VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 50 ASIA-PACIFIC VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 51 ASIA-PACIFIC VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 52 ASIA-PACIFIC ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 53 ASIA-PACIFIC ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 54 ASIA-PACIFIC ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 55 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 56 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 57 ASIA-PACIFIC PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 58 ASIA-PACIFIC ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 59 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 60 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 61 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 62 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 63 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 64 INDIA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 65 INDIA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 66 INDIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 67 INDIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 68 INDIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 69 INDIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 70 INDIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 71 INDIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 72 INDIA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 73 INDIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 74 INDIA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 75 INDIA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 76 INDIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 77 INDIA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 78 INDIA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 79 INDIA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 80 INDIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 81 CHINA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 82 CHINA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 83 CHINA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 84 CHINA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 85 CHINA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 86 CHINA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 87 CHINA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 88 CHINA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 89 CHINA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 90 CHINA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 91 CHINA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 92 CHINA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 93 CHINA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 94 CHINA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 95 CHINA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 96 CHINA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 97 CHINA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 98 JAPAN DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 99 JAPAN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 100 JAPAN VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 101 JAPAN VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 102 JAPAN VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 103 JAPAN ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 104 JAPAN ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 105 JAPAN ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 106 JAPAN DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 107 JAPAN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 108 JAPAN PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 109 JAPAN ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 110 JAPAN DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 111 JAPAN DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 112 JAPAN DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 113 JAPAN DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 114 JAPAN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 115 INDONESIA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 116 INDONESIA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 117 INDONESIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 118 INDONESIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 119 INDONESIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 120 INDONESIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 121 INDONESIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 122 INDONESIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 123 INDONESIA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 124 INDONESIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 125 INDONESIA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 126 INDONESIA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 127 INDONESIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 128 INDONESIA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 129 INDONESIA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 130 INDONESIA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 131 INDONESIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 132 MALAYSIA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 133 MALAYSIA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 134 MALAYSIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 135 MALAYSIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 136 MALAYSIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 137 MALAYSIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 138 MALAYSIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 139 MALAYSIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 140 MALAYSIA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 141 MALAYSIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 142 MALAYSIA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 143 MALAYSIA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 144 MALAYSIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 145 MALAYSIA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 146 MALAYSIA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 147 MALAYSIA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 148 MALAYSIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 149 THAILAND DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 150 THAILAND DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 151 THAILAND VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 152 THAILAND VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 153 THAILAND VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 154 THAILAND ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 155 THAILAND ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 156 THAILAND ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 157 THAILAND DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 158 THAILAND DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 159 THAILAND PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 160 THAILAND ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 161 THAILAND DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 162 THAILAND DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 163 THAILAND DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 164 THAILAND DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 165 THAILAND DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 166 AUSTRALIA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 167 AUSTRALIA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 168 AUSTRALIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 169 AUSTRALIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 170 AUSTRALIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 171 AUSTRALIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 172 AUSTRALIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 173 AUSTRALIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 174 AUSTRALIA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 175 AUSTRALIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 176 AUSTRALIA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 177 AUSTRALIA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 178 AUSTRALIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 179 AUSTRALIA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 180 AUSTRALIA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 181 AUSTRALIA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 182 AUSTRALIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 183 SOUTH KOREA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 184 SOUTH KOREA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 185 SOUTH KOREA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 186 SOUTH KOREA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 187 SOUTH KOREA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 188 SOUTH KOREA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 189 SOUTH KOREA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 190 SOUTH KOREA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 191 SOUTH KOREA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 192 SOUTH KOREA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 193 SOUTH KOREA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 194 SOUTH KOREA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 195 SOUTH KOREA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 196 SOUTH KOREA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 197 SOUTH KOREA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 198 SOUTH KOREA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 199 SOUTH KOREA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 200 SINGAPORE DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 201 SINGAPORE DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 202 SINGAPORE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 203 SINGAPORE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 204 SINGAPORE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 205 SINGAPORE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 206 SINGAPORE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 207 SINGAPORE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 208 SINGAPORE DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 209 SINGAPORE DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 210 SINGAPORE PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 211 SINGAPORE ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 212 SINGAPORE DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 213 SINGAPORE DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 214 SINGAPORE DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 215 SINGAPORE DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 216 SINGAPORE DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 217 PHILIPPINES DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 218 PHILIPPINES DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 219 PHILIPPINES VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 220 PHILIPPINES VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 221 PHILIPPINES VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 222 PHILIPPINES ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 223 PHILIPPINES ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 224 PHILIPPINES ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 225 PHILIPPINES DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 226 PHILIPPINES DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 227 PHILIPPINES PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 228 PHILIPPINES ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 229 PHILIPPINES DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 230 PHILIPPINES DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 231 PHILIPPINES DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 232 PHILIPPINES DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 233 PHILIPPINES DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 234 REST OF ASIA-PACIFIC DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)

LIST OF FIGURES

• FIGURE 1 ASIA-PACIFIC DENGUE TREATMENT MARKET: SEGMENTATION
• FIGURE 2 ASIA-PACIFIC DENGUE TREATMENT MARKET: DATA TRIANGULATION
• FIGURE 3 ASIA-PACIFIC DENGUE TREATMENT MARKET: DROC ANALYSIS
• FIGURE 4 ASIA-PACIFIC DENGUE TREATMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
• FIGURE 5 ASIA-PACIFIC DENGUE TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
• FIGURE 6 ASIA-PACIFIC DENGUE TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
• FIGURE 7 ASIA-PACIFIC DENGUE TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID
• FIGURE 8 ASIA-PACIFIC DENGUE TREATMENT MARKET: DBMR MARKET POSITION GRID
• FIGURE 9 ASIA-PACIFIC DENGUE TREATMENT MARKET: VENDOR SHARE ANALYSIS
• FIGURE 10 ASIA-PACIFIC DENGUE TREATMENT MARKET: SEGMENTATION
• FIGURE 11 GROWING PHARMACEUTICAL INDUSTRY IS DRIVING THE GROWTH OF THE ASIA-PACIFIC DENGUE TREATMENT MARKET FROM 2024 TO 2031
• FIGURE 12 ON THE BASIS OF STRAINS, THE DENV-2 SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC DENGUE TREATMENT MARKET IN 2024 AND 2031
• FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC DENGUE TREATMENT MARKET
• FIGURE 14 FINANCIAL BUDGET FOR VECTOR-BORNE -DISEASES INCLUDING DENGUE IN INDIA
• FIGURE 15 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY STRAINS, 2023
• FIGURE 16 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY STRAINS, 2024-2031 (USD MILLION)
• FIGURE 17 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY STRAINS, CAGR (2024-2031)
• FIGURE 18 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY STRAINS, LIFELINE CURVE
• FIGURE 19 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY TYPE, 2023
• FIGURE 20 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY TYPE, 2024-2031 (USD MILLION)
• FIGURE 21 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY TYPE, CAGR (2024-2031)
• FIGURE 22 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY TYPE, LIFELINE CURVE
• FIGURE 23 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY SEVERITY, 2023
• FIGURE 24 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY SEVERITY, 2024-2031 (USD MILLION)
• FIGURE 25 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY SEVERITY, CAGR (2024-2031)
• FIGURE 26 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY SEVERITY, LIFELINE CURVE
• FIGURE 27 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2023
• FIGURE 28 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2024-2031 (USD MILLION)
• FIGURE 29 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2024-2031)
• FIGURE 30 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
• FIGURE 31 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, 2023
• FIGURE 32 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
• FIGURE 33 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)
• FIGURE 34 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
• FIGURE 35 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY GENDER, 2023
• FIGURE 36 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY GENDER, 2024-2031 (USD MILLION)
• FIGURE 37 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY GENDER, CAGR (2024-2031)
• FIGURE 38 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY GENDER, LIFELINE CURVE
• FIGURE 39 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY AGE, 2023
• FIGURE 40 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY AGE, 2024-2031 (USD MILLION)
• FIGURE 41 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY AGE, CAGR (2024-2031)
• FIGURE 42 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY AGE, LIFELINE CURVE
• FIGURE 43 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY END USER, 2023
• FIGURE 44 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY END USER, 2024-2031 (USD MILLION)
• FIGURE 45 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY END USER, CAGR (2024-2031)
• FIGURE 46 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY END USER, LIFELINE CURVE
• FIGURE 47 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2023
• FIGURE 48 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
• FIGURE 49 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
• FIGURE 50 ASIA-PACIFIC DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
• FIGURE 51 ASIA-PACIFIC DENGUE TREATMENT MARKET: SNAPSHOT (2023)
• FIGURE 52 ASIA-PACIFIC DENGUE TREATMENT MARKET: COMPANY SHARE 2022 (%)